• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-19A
Device Problems Obstruction of Flow (2423); Material Split, Cut or Torn (4008)
Patient Problem Valvular Stenosis (2697)
Event Date 06/12/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2015, a 19mm sjm trifecta valve was implanted in the patient's aortic position with non-everting mattress suture technique using pledgets in another hospital(national cerebral and cardiovascular center).An abbott sizer was used in the surgery.Severe aortic stenosis thought to be due to calcification was found in the echocardiogram on (b)(6) 2020.On (b)(6) 2020, a re-do avr was performed and the trifecta valve was explanted, replaced with a 19mm magna mitral ease(manufacturer: edwards lifesciences) after performing aortic annular enlargement.Upon explant, a tear on the stent strut part between the lcc and rcc commissure leading vertically to nadir was visually confirmed, thus the surgeon concluded that the issue was not due to the calcification, but due to the tear on the valve in the early stage after the implant.The patient is in stable condition postoperatively.
 
Manufacturer Narrative
Additional information: d10, h3, h6.Explant was reported due to stenosis.The investigation found that all three leaflets contained tears.Leaflets 1 and 3 contained previous incisions.There was circumferential fibrous pannus ingrowth on the inflow surface which narrowed the inflow diameter.The pannus extended into the bases of leaflets 2 and 3.There was fungal hyphae on the surface of the valve, which was consistent with a contaminant.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The circumferential inflow pannus noted could have contributed to the reported stenosis.The cause of the tear could not be conclusively determined; however, the fibrous pannus ingrowth noted had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA)
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key10270539
MDR Text Key199287701
Report Number3001883144-2020-00069
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052016
UDI-Public05414734052016
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 08/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/20/2016
Device Model NumberTF-19A
Device Catalogue NumberTF-19A
Device Lot Number5013182
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/24/2020
Was the Report Sent to FDA? No
Date Manufacturer Received08/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age81 YR
-
-